RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD (NCT02989935)

🧪 Interventions in This Study

• Ventilation (PROCEDURE)
• Parasternal EMG (PROCEDURE)
• Phrenic magnetic stimulation (PROCEDURE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Calgary — Calgary, Alberta

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Copd

• Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSound — Calgary,
• Impairments That Affect Correct Inhaler Use in COPD — Birmingham, Alabama
• The Development of an Integrated Physical Activity and Mental Health Intervention for Veterans With COPD, Emotion Distress, and Low Physical Activity — Boston, Massachusetts
• A Study to Evaluate Solrikitug in Participants With COPD (ZION) — Birmingham, Alabama
• Evaluation of the Safety and Efficacy of TLD in Patients with COPD — Birmingham, Alabama

Explore by condition: All Copd clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.